BioLife Solutions Inc.
BLFS | NASDAQ
$38.04
+$0.86 (+2.31%)
Sep 22, 2026, 12:34 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -96.72 | -59 | -10.69 | -5.53 | -162.04 | 598.05 |
PEG Ratio | 2.24 | 0.83 | 0.20 | 0 | 0.36 | -3.35 |
PS Ratio | 12 | 14.54 | 9.37 | 10.14 | 12.04 | 22.65 |
PB Ratio | 3.10 | 3.43 | 2.10 | 2.12 | 2.99 | 5.31 |
P/FCF Ratio | 2.78K | 229.80 | -37.63 | -40.96 | -108.54 | 578.77 |
P/OCF Ratio | 57.40 | 141.85 | -56.84 | -91.08 | -296.74 | 167.19 |
OCF/S Ratio | 20.91 | 10.25 | -16.48 | -11.13 | -4.06 | 13.55 |
Debt / Equity Ratio | 0.05 | 0.09 | 0.10 | 0.12 | 0.06 | 0.05 |
Quick Ratio | 4.63 | 3.66 | 1.83 | 2.32 | 2.28 | 6.62 |
Current Ratio | 5.94 | 4.54 | 2.86 | 3.11 | 2.95 | 7.37 |
Asset Turnover | 0.24 | 0.21 | 0.18 | 0.17 | 0.22 | 0.20 |
Interest Coverage | -0.40 | -9.92 | -12.94 | -8.62 | -72.49 | -185.11 |
Return on Equity | -3.26% | -5.78% | -19.67% | -38.39% | -1.85% | 1.30% |
Return on Assets | -2.99% | -5.05% | -16.10% | -31.05% | -1.61% | 1.14% |
Return on Invested Capital | -0.28% | -1.87% | -6.20% | 0.12% | -2.10% | 2.33% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 64.56% | 65.25% | 61.63% | 61.53% | 24.21% | 57.07% |
Net Profit Margin | -12.61% | -24.54% | -87.57% | -183.38% | -7.48% | 5.55% |
Pretax Profit Margin | -12.56% | -13.89% | -24.35% | -6.36% | -24.36% | -2.66% |
Operating Profit Margin | -1.12% | -8.67% | -30.90% | -7.77% | -29.51% | -6.93% |
FCF Margin | 0.43% | 6.33% | -24.89% | -24.76% | -11.10% | 3.91% |
EBITDA Margin | 3.75% | 1.86% | -59.64% | -162.89% | -13.98% | 3.08% |
Add to Watchlist
Select watchlists to add or remove BLFS